Foghorn Therapeutics FHTX
NASDAQ FHTX
$3.56 +0.04 (+1.13%)
As of: Sep 30, 2026 · 3:59 PM EDT

Foghorn Therapeutics (FHTX) Times Interest Earned (2019 - 2021)

Updated

Foghorn Therapeutics' Times Interest Earned was -65.92 in Q4 2021, compared with -64.73 a year earlier.

Analysis

Foghorn Therapeutics (FHTX) Times Interest Earned (2019 - 2021) Analysis & Trends

For FY2021, Times Interest Earned at Foghorn Therapeutics came in at -52.85.

  • In earlier years, Times Interest Earned was -70.00 in FY2020 and -94.60 in FY2019.
  • The Q4 2021 figure marks the lowest quarterly Times Interest Earned since Q3 2020.
  • Per Business Quant data, FHTX's Times Interest Earned in the three quarters before Q4 2021 was -52.63 (Q3 2021), -46.99 (Q2 2021) and -47.59 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.41
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 10.28
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 7.27
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 5.22
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Foghorn Therapeutics 206.67 Mn -119.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -65.92
Sep 30, 2021 -52.63
Jun 30, 2021 -46.99
Mar 31, 2021 -47.59
Dec 31, 2020 -64.73
Sep 30, 2020 -91.53
Jun 30, 2020 -78.48
Mar 31, 2020 -53.19
Dec 31, 2019 -85.31
Sep 30, 2019 -115.93
API Access

Foghorn Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=FHTX&period=max&api_key=YOUR_API_KEY